Please check your internet connection and try again.
# IV Hydrocortisone for Acute Asthma
## Overview
Hydrocortisone is a short-acting systemic corticosteroid used when rapid anti-inflammatory action is required. In the setting of acute asthma exacerbations, it is typically reserved for patients unable to tolerate oral therapy (e.g., severe vomiting, inability to swallow, or intubated patients).
## Primary Indications
* Management of acute, severe asthma exacerbations unresponsive to initial intensive treatment.
* Acute asthma requiring parenteral administration when oral intake is compromised.
## Adult Dosing
* **Initial Dose:** 100 mg IV every 6 to 8 hours.
* **Duration:** Usually continued until the patient can transition to oral corticosteroids (e.g., prednisone) or until clinical resolution.
## Pediatric Dosing
* **Dose:** 2 mg/kg to 4 mg/kg IV per dose.
* **Frequency:** Every 6 hours.
* **Maximum:** 100 mg per dose.
* *Note:* Guidelines often prefer oral prednisolone for most pediatric exacerbations; IV administration should be limited to patients unable to tolerate oral medication or those in respiratory failure.
## Dose Adjustments
* **Renal/Hepatic Impairment:** No specific adjustment required for short-term "burst" therapy in acute asthma.
* **Clinical Response:** Dosing is titration-based; therapy should be switched to the oral route as soon as clinically feasible to minimize systemic exposure.
## Contraindications
* Known hypersensitivity to hydrocortisone or any component of the formulation.
* Systemic fungal infections (unless treated concurrently).
## Adverse Effects
* **Short-term:** Hyperglycemia (even in non-diabetics), hypertension, fluid retention, hypokalemia, and neuropsychiatric effects (agitation, insomnia, psychosis).
* **GI:** Increased risk of occult GI bleeding or peptic ulceration, particularly with concomitant NSAIDs.
## Key Drug Interactions
* **NSAIDs:** Increased risk of gastrointestinal ulceration/bleeding.
* **Diuretics:** Potential for additive potassium loss (hypokalemia).
* **Insulin/Antidiabetics:** Hydrocortisone can antagonize the glucose-lowering effects of antidiabetic agents.
## Monitoring
* **Efficacy:** Monitor respiratory rate, oxygen saturation, physical assessment (wheezing, accessory muscle use), and peak expiratory flow (PEF) or FEV1 if applicable.
* **Safety:** Monitor blood glucose levels (especially in patients with diabetes or those at high risk for hyperglycemia) and blood pressure. Assess for signs of GI distress.
## Clinical Pearls
* **Preference for Oral:** Systemic corticosteroids for acute asthma are equally effective via the oral route (bioavailability is excellent) and should be preferred unless IV access is necessary for other reasons.
* **No "Steroid-Sparing" Benefit:** Intravenous steroids do not provide a faster clinical onset or superior outcomes compared to equivalent doses of oral prednisone/prednisolone.
* **Protocol Variation:** Always verify dose and interval against local institutional asthma management protocols, as clinical pathways may prioritize specific corticosteroid agents (e.g., methylprednisolone).
***
**Educational Disclaimer:** This information is for educational purposes only. Drug dosing, indications, and safety information are subject to change. Always verify current prescribing information, institutional protocols, and patient-specific factors with a qualified healthcare provider or official drug database before administering medication.
